25 XP   0   0   10

Benitec Biopharma Ltd ADR
Buy, Hold or Sell?

Let's analyse Benitec together

PenkeI guess you are interested in Benitec Biopharma Ltd ADR. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Benitec Biopharma Ltd ADR. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Benitec Biopharma Ltd ADR

I send you an email if I find something interesting about Benitec Biopharma Ltd ADR.

Quick analysis of Benitec (30 sec.)










What can you expect buying and holding a share of Benitec? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
$5.97
Expected worth in 1 year
$8.47
How sure are you?
39.5%

+ What do you gain per year?

Total Gains per Share
$2.50
Return On Investment
36.4%

For what price can you sell your share?

Current Price per Share
$6.86
Expected price per share
$4.75 - $18.02
How sure are you?
50%

1. Valuation of Benitec (5 min.)




Live pricePrice per Share (EOD)

$6.86

Intrinsic Value Per Share

$-70.80 - $-83.13

Total Value Per Share

$-64.83 - $-77.16

2. Growth of Benitec (5 min.)




Is Benitec growing?

Current yearPrevious yearGrowGrow %
How rich?$15.4m$8.5m$2.1m20.3%

How much money is Benitec making?

Current yearPrevious yearGrowGrow %
Making money-$5.4m-$4.8m-$642.2k-11.7%
Net Profit Margin-18,711.2%-16,609.4%--

How much money comes from the company's main activities?

3. Financial Health of Benitec (5 min.)




4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#619 / 1009

Most Revenue
#684 / 1009

Most Profit
#441 / 1009

Most Efficient
#960 / 1009

What can you expect buying and holding a share of Benitec? (5 min.)

Welcome investor! Benitec's management wants to use your money to grow the business. In return you get a share of Benitec.

What can you expect buying and holding a share of Benitec?

First you should know what it really means to hold a share of Benitec. And how you can make/lose money.

Speculation

The Price per Share of Benitec is $6.86. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Benitec.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Benitec, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $5.97. Based on the TTM, the Book Value Change Per Share is $0.62 per quarter. Based on the YOY, the Book Value Change Per Share is $-0.18 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Benitec.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-2.62-38.2%-2.13-31.0%-0.52-7.6%-1.23-17.9%-1.38-20.1%
Usd Book Value Change Per Share-2.64-38.5%0.629.1%-0.18-2.6%0.294.3%0.152.2%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share-2.64-38.5%0.629.1%-0.18-2.6%0.294.3%0.152.2%
Usd Price Per Share3.23-1.68-1.01-2.80-2.97-
Price to Earnings Ratio-0.31--0.17--31,210.57--6,242.66--3,286.35-
Price-to-Total Gains Ratio-1.22--0.28--24,553.56--5,169.18--2,806.27-
Price to Book Ratio0.54-1.02-89,744.02-17,950.25-9,448.17-
Price-to-Total Gains Ratio-1.22--0.28--24,553.56--5,169.18--2,806.27-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share6.86
Number of shares145
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.620.29
Usd Total Gains Per Share0.620.29
Gains per Quarter (145 shares)90.5542.63
Gains per Year (145 shares)362.22170.52
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
103623520171161
207247140341332
30108710760512503
40144914380682674
50181118000853845
6021732162010231016
7025362524011941187
8028982886013641358
9032603248015351529
10036223610017051700

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%0.012.00.00.0%0.020.00.00.0%5.032.01.013.2%5.032.02.012.8%
Book Value Change Per Share1.03.00.025.0%4.08.00.033.3%8.011.01.040.0%15.020.03.039.5%16.020.03.041.0%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.020.00.0%0.00.038.00.0%0.00.039.00.0%
Total Gains per Share1.03.00.025.0%4.08.00.033.3%8.011.01.040.0%15.020.03.039.5%16.020.03.041.0%

Fundamentals of Benitec

About Benitec Biopharma Ltd ADR

Benitec Biopharma Inc., a clinical-stage biotechnology company, focuses on the development of novel genetic medicines. The company develops DNA-directed RNA interference-based therapeutics for chronic and life-threatening human conditions. It is developing BB-301, an adeno-associated virus based gene therapy agent for treating oculopharyngeal muscular dystrophy. The company was incorporated in 1995 and is headquartered in Hayward, California.

Fundamental data was last updated by Penke on 2024-04-11 02:49:04.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is unable to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Benitec Biopharma Ltd ADR.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Benitec earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Benitec to the Biotechnology industry mean.
  • A Net Profit Margin of 0.0% means that $0.00 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Benitec Biopharma Ltd ADR:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-18,711.2%+18,711.2%
TTM-18,711.2%YOY-16,609.4%-2,101.8%
TTM-18,711.2%5Y-66,793.3%+48,082.0%
5Y-66,793.3%10Y-36,191.8%-30,601.4%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--200.1%+200.1%
TTM-18,711.2%-216.8%-18,494.4%
YOY-16,609.4%-288.3%-16,321.1%
5Y-66,793.3%-449.1%-66,344.2%
10Y-36,191.8%-605.5%-35,586.3%
1.1.2. Return on Assets

Shows how efficient Benitec is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Benitec to the Biotechnology industry mean.
  • -31.8% Return on Assets means that Benitec generated $-0.32 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Benitec Biopharma Ltd ADR:

  • The MRQ is -31.8%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -53.1%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-31.8%TTM-53.1%+21.3%
TTM-53.1%YOY-48.9%-4.2%
TTM-53.1%5Y-51.4%-1.7%
5Y-51.4%10Y-31.9%-19.5%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-31.8%-13.3%-18.5%
TTM-53.1%-12.8%-40.3%
YOY-48.9%-11.7%-37.2%
5Y-51.4%-13.9%-37.5%
10Y-31.9%-15.7%-16.2%
1.1.3. Return on Equity

Shows how efficient Benitec is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Benitec to the Biotechnology industry mean.
  • -43.9% Return on Equity means Benitec generated $-0.44 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Benitec Biopharma Ltd ADR:

  • The MRQ is -43.9%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -618.2%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-43.9%TTM-618.2%+574.2%
TTM-618.2%YOY-81.2%-537.0%
TTM-618.2%5Y-174.2%-444.0%
5Y-174.2%10Y-96.9%-77.3%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-43.9%-16.9%-27.0%
TTM-618.2%-16.1%-602.1%
YOY-81.2%-15.1%-66.1%
5Y-174.2%-19.3%-154.9%
10Y-96.9%-20.2%-76.7%

1.2. Operating Efficiency of Benitec Biopharma Ltd ADR.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Benitec is operating .

  • Measures how much profit Benitec makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Benitec to the Biotechnology industry mean.
  • An Operating Margin of 0.0% means the company generated $0.00  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Benitec Biopharma Ltd ADR:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-18,545.4%+18,545.4%
TTM-18,545.4%YOY-16,800.5%-1,744.9%
TTM-18,545.4%5Y-63,871.8%+45,326.4%
5Y-63,871.8%10Y-34,518.3%-29,353.5%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--296.2%+296.2%
TTM-18,545.4%-232.5%-18,312.9%
YOY-16,800.5%-298.2%-16,502.3%
5Y-63,871.8%-492.1%-63,379.7%
10Y-34,518.3%-632.4%-33,885.9%
1.2.2. Operating Ratio

Measures how efficient Benitec is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 0.00 means that the operating costs are $0.00 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Benitec Biopharma Ltd ADR:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM186.245-186.245
TTM186.245YOY169.291+16.954
TTM186.2455Y656.873-470.628
5Y656.87310Y359.022+297.852
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-3.231-3.231
TTM186.2453.310+182.935
YOY169.2913.890+165.401
5Y656.8735.739+651.134
10Y359.0227.876+351.146

1.3. Liquidity of Benitec Biopharma Ltd ADR.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Benitec is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 3.62 means the company has $3.62 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Benitec Biopharma Ltd ADR:

  • The MRQ is 3.619. The company is very able to pay all its short-term debts. +2
  • The TTM is 3.182. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ3.619TTM3.182+0.437
TTM3.182YOY4.154-0.972
TTM3.1825Y8.423-5.241
5Y8.42310Y11.642-3.219
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ3.6193.890-0.271
TTM3.1824.173-0.991
YOY4.1545.344-1.190
5Y8.4236.126+2.297
10Y11.6426.448+5.194
1.3.2. Quick Ratio

Measures if Benitec is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Benitec to the Biotechnology industry mean.
  • A Quick Ratio of 3.55 means the company can pay off $3.55 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Benitec Biopharma Ltd ADR:

  • The MRQ is 3.555. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 3.001. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ3.555TTM3.001+0.554
TTM3.001YOY3.970-0.970
TTM3.0015Y6.280-3.279
5Y6.28010Y9.849-3.570
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ3.5553.514+0.041
TTM3.0013.998-0.997
YOY3.9705.380-1.410
5Y6.2806.105+0.175
10Y9.8496.404+3.445

1.4. Solvency of Benitec Biopharma Ltd ADR.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Benitec assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Benitec to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.28 means that Benitec assets are financed with 27.6% credit (debt) and the remaining percentage (100% - 27.6%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Benitec Biopharma Ltd ADR:

  • The MRQ is 0.276. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.458. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.276TTM0.458-0.183
TTM0.458YOY0.302+0.156
TTM0.4585Y0.221+0.237
5Y0.22110Y0.148+0.074
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.2760.339-0.063
TTM0.4580.336+0.122
YOY0.3020.271+0.031
5Y0.2210.366-0.145
10Y0.1480.389-0.241
1.4.2. Debt to Equity Ratio

Measures if Benitec is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Benitec to the Biotechnology industry mean.
  • A Debt to Equity ratio of 38.0% means that company has $0.38 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Benitec Biopharma Ltd ADR:

  • The MRQ is 0.380. The company is very able to pay all its debts with equity. +2
  • The TTM is 5.609. The company is unable to pay all its debts with equity. -1
Trends
Current periodCompared to+/- 
MRQ0.380TTM5.609-5.229
TTM5.609YOY0.494+5.115
TTM5.6095Y1.301+4.308
5Y1.30110Y0.719+0.582
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.3800.388-0.008
TTM5.6090.402+5.207
YOY0.4940.335+0.159
5Y1.3010.426+0.875
10Y0.7190.461+0.258

2. Market Valuation of Benitec Biopharma Ltd ADR

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Benitec generates.

  • Above 15 is considered overpriced but always compare Benitec to the Biotechnology industry mean.
  • A PE ratio of -0.31 means the investor is paying $-0.31 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Benitec Biopharma Ltd ADR:

  • The EOD is -0.654. Based on the earnings, the company is expensive. -2
  • The MRQ is -0.308. Based on the earnings, the company is expensive. -2
  • The TTM is -0.175. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.654MRQ-0.308-0.346
MRQ-0.308TTM-0.175-0.133
TTM-0.175YOY-31,210.570+31,210.396
TTM-0.1755Y-6,242.658+6,242.483
5Y-6,242.65810Y-3,286.349-2,956.309
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-0.654-2.264+1.610
MRQ-0.308-2.629+2.321
TTM-0.175-2.680+2.505
YOY-31,210.570-4.145-31,206.425
5Y-6,242.658-6.257-6,236.401
10Y-3,286.349-6.254-3,280.095
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Benitec Biopharma Ltd ADR:

  • The EOD is -0.829. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -0.390. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -0.222. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.829MRQ-0.390-0.439
MRQ-0.390TTM-0.222-0.168
TTM-0.222YOY-31,326.248+31,326.025
TTM-0.2225Y-6,266.283+6,266.061
5Y-6,266.28310Y-3,299.576-2,966.708
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-0.829-2.973+2.144
MRQ-0.390-3.333+2.943
TTM-0.222-3.553+3.331
YOY-31,326.248-5.605-31,320.643
5Y-6,266.283-8.376-6,257.907
10Y-3,299.576-8.865-3,290.711
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Benitec is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 0.54 means the investor is paying $0.54 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Benitec Biopharma Ltd ADR:

  • The EOD is 1.150. Based on the equity, the company is underpriced. +1
  • The MRQ is 0.541. Based on the equity, the company is cheap. +2
  • The TTM is 1.017. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD1.150MRQ0.541+0.608
MRQ0.541TTM1.017-0.476
TTM1.017YOY89,744.017-89,743.000
TTM1.0175Y17,950.249-17,949.232
5Y17,950.24910Y9,448.170+8,502.080
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD1.1501.896-0.746
MRQ0.5412.115-1.574
TTM1.0172.093-1.076
YOY89,744.0172.884+89,741.133
5Y17,950.2493.542+17,946.707
10Y9,448.1703.916+9,444.254
2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Benitec Biopharma Ltd ADR.

3.1. Institutions holding Benitec Biopharma Ltd ADR

Institutions are holding 55.017% of the shares of Benitec Biopharma Ltd ADR.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2023-12-31Franklin Resources Inc22.69050.000958823700
2023-12-31Suvretta Capital Management, LLC7.87750.029820422000
2023-12-31Adage Capital Partners Gp LLC7.29770.001318918800
2023-12-31HHG PLC6.95870.0004180399-25771-12.4999
2023-09-30Citadel Advisors Llc2.68150.000169515695150
2023-12-31Vanguard Group Inc0.6442016701167010
2023-12-31Geode Capital Management, LLC0.386701002400
2023-12-31Morgan Stanley - Brokerage Accounts0.19670510051000
2023-12-31Tower Research Capital LLC0.09620.0001249522991172.9592
2023-12-31UBS Group AG0.0240622513470.6422
2023-12-31Rhumbline Advisers0.0072018600
2023-12-31Group One Trading, LP0.003408900
2023-12-31Wells Fargo & Co0.0007017430.7692
2023-09-30State Street Corporation000-1261-100
2023-12-31Rosenberg Matthew Hamilton000-23-100
2023-09-30Private Advisor Group, LLC000-774-100
2023-09-30Northern Trust Corp000-695-100
2023-09-30Virtu Financial LLC000-3110-100
2023-09-30WEALTHTRUST AXIOM LLC000-762-100
Total 48.8650.03261266793+61736+4.9%

3.2. Funds holding Benitec Biopharma Ltd ADR

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2024-02-29Franklin Biotechnology Discovery A14.07510.179136488700
2024-02-29Franklin Biotechnology Discv A(acc)USD8.61550.057122335000
2024-02-29Vanguard Institutional Extnd Mkt Idx Tr0.64420.00011670100
2024-01-31Fidelity Extended Market Index0.34550.0001895700
2024-01-31Fidelity Nasdaq Composite Index0.0268069600
2024-02-29State St US Extended Mkt Indx NL Cl C0.02140.000155400
2023-12-31SSgA U.S. Extended Market Index Class I0.02140.000155400
2023-12-31NT Ext Equity Mkt Idx Fd - NL0.0183047500
2023-12-31NT Ext Equity Mkt Idx Fd - DC - NL - T20.0147038110.2632
2024-01-31Fidelity Series Total Market Index0.0127032800
2023-12-31Northern Trust Extended Eq Market Idx0.0085022100
2023-12-31NT Ext Equity Mkt Idx Fd - L0.0085022100
2023-12-31SSgA U.S. Total Market Index Strategy0.00620160-4-2.439
2024-01-31Spartan Total Market Index Pool E0.001704300
2023-12-31NT Ext Eq Mkt Indx Fd DC Lending Tier 50.000601500
Total 23.82110.2366617543-30.0%

3.3. Insider Transactions

Insiders are holding 6.809% of the shares of Benitec Biopharma Ltd ADR.

DateOwnerTypeAmountPricePost Transaction AmountLink
2021-12-09Steven Michael OliveiraBUY62051.68
2021-11-29Steven Michael OliveiraBUY223254.06
2021-05-03Steven Michael OliveiraBUY238272.25
2021-04-30Steven Michael OliveiraBUY705871.06
2021-04-28Steven Michael OliveiraBUY588292.65

4. Summary

4.1. Key Performance Indicators

The key performance indicators of Benitec Biopharma Ltd ADR compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---2.6380.625-522%-0.178-93%0.294-997%0.151-1846%
Book Value Per Share--5.9674.117+45%0.867+588%3.619+65%4.903+22%
Current Ratio--3.6193.182+14%4.154-13%8.423-57%11.642-69%
Debt To Asset Ratio--0.2760.458-40%0.302-9%0.221+24%0.148+86%
Debt To Equity Ratio--0.3805.609-93%0.494-23%1.301-71%0.719-47%
Dividend Per Share----0%-0%-0%-0%
Eps---2.622-2.129-19%-0.522-80%-1.229-53%-1.378-47%
Free Cash Flow Per Share---2.069-1.742-16%-0.563-73%-1.032-50%-0.991-52%
Free Cash Flow To Equity Per Share---2.0540.973-311%-0.593-71%0.661-411%0.277-841%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%0.974+3%
Intrinsic Value_10Y_max---83.126--------
Intrinsic Value_10Y_min---70.798--------
Intrinsic Value_1Y_max---5.453--------
Intrinsic Value_1Y_min---5.354--------
Intrinsic Value_3Y_max---18.576--------
Intrinsic Value_3Y_min---17.690--------
Intrinsic Value_5Y_max---34.343--------
Intrinsic Value_5Y_min---31.687--------
Market Cap17784069.800+53%8373548.9004342385.061+93%479340746603.275-100%95874894605.696-100%50473192729.614-100%
Net Profit Margin----187.1120%-166.0940%-667.9330%-361.9180%
Operating Margin----185.4540%-168.0050%-638.7180%-345.1830%
Operating Ratio---186.245-100%169.291-100%656.873-100%359.022-100%
Pb Ratio1.150+53%0.5411.017-47%89744.017-100%17950.249-100%9448.170-100%
Pe Ratio-0.654-112%-0.308-0.175-43%-31210.570+10135123%-6242.658+2027121%-3286.349+1067099%
Price Per Share6.860+53%3.2301.675+93%1.009+220%2.799+15%2.969+9%
Price To Free Cash Flow Ratio-0.829-112%-0.390-0.222-43%-31326.248+8028291%-6266.283+1605843%-3299.576+845526%
Price To Total Gains Ratio-2.601-112%-1.225-0.284-77%-24553.558+2004990%-5169.185+422025%-2806.272+229066%
Quick Ratio--3.5553.001+18%3.970-10%6.280-43%9.849-64%
Return On Assets---0.318-0.531+67%-0.489+54%-0.514+62%-0.319+0%
Return On Equity---0.439-6.182+1307%-0.812+85%-1.742+296%-0.969+120%
Total Gains Per Share---2.6380.625-522%-0.178-93%0.294-997%0.151-1846%
Usd Book Value--15470000.00010673250.000+45%8502250.000+82%10720566.674+44%13931264.292+11%
Usd Book Value Change Per Share---2.6380.625-522%-0.178-93%0.294-997%0.151-1846%
Usd Book Value Per Share--5.9674.117+45%0.867+588%3.619+65%4.903+22%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---2.622-2.129-19%-0.522-80%-1.229-53%-1.378-47%
Usd Free Cash Flow---5365000.000-4516750.000-16%-4544500.000-15%-3293780.776-39%-2806035.296-48%
Usd Free Cash Flow Per Share---2.069-1.742-16%-0.563-73%-1.032-50%-0.991-52%
Usd Free Cash Flow To Equity Per Share---2.0540.973-311%-0.593-71%0.661-411%0.277-841%
Usd Market Cap17784069.800+53%8373548.9004342385.061+93%479340746603.275-100%95874894605.696-100%50473192729.614-100%
Usd Price Per Share6.860+53%3.2301.675+93%1.009+220%2.799+15%2.969+9%
Usd Profit---6798000.000-5468250.000-20%-4826000.000-29%-3911425.536-42%-2869822.830-58%
Usd Revenue---15250.000-100%139750.000-100%103963.767-100%669562.691-100%
Usd Total Gains Per Share---2.6380.625-522%-0.178-93%0.294-997%0.151-1846%
 EOD+5 -3MRQTTM+16 -15YOY+11 -205Y+10 -2110Y+11 -21

4.2. Fundamental Score

Let's check the fundamental score of Benitec Biopharma Ltd ADR based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-0.654
Price to Book Ratio (EOD)Between0-11.150
Net Profit Margin (MRQ)Greater than00.000
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than13.555
Current Ratio (MRQ)Greater than13.619
Debt to Asset Ratio (MRQ)Less than10.276
Debt to Equity Ratio (MRQ)Less than10.380
Return on Equity (MRQ)Greater than0.15-0.439
Return on Assets (MRQ)Greater than0.05-0.318
Total4/10 (40.0%)

4.3. Technical Score

Let's check the technical score of Benitec Biopharma Ltd ADR based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5066.141
Ma 20Greater thanMa 505.681
Ma 50Greater thanMa 1004.933
Ma 100Greater thanMa 2004.017
OpenGreater thanClose6.570
Total4/5 (80.0%)



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in USD. All numbers in thousands.

Summary
Total Assets21,353
Total Liabilities5,883
Total Stockholder Equity15,470
 As reported
Total Liabilities 5,883
Total Stockholder Equity+ 15,470
Total Assets = 21,353

Assets

Total Assets21,353
Total Current Assets20,796
Long-term Assets527
Total Current Assets
Cash And Cash Equivalents 20,374
Net Receivables 53
Inventory 14
Other Current Assets 355
Total Current Assets  (as reported)20,796
Total Current Assets  (calculated)20,796
+/-0
Long-term Assets
Property Plant Equipment 451
Long-term Assets Other 76
Long-term Assets  (as reported)527
Long-term Assets  (calculated)527
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities5,746
Long-term Liabilities137
Total Stockholder Equity15,470
Total Current Liabilities
Short-term Debt 286
Accounts payable 2,619
Other Current Liabilities 5,460
Total Current Liabilities  (as reported)5,746
Total Current Liabilities  (calculated)8,365
+/- 2,619
Long-term Liabilities
Capital Lease Obligations Min Short Term Debt137
Long-term Liabilities  (as reported)137
Long-term Liabilities  (calculated)137
+/-0
Total Stockholder Equity
Retained Earnings -180,641
Accumulated Other Comprehensive Income -952
Other Stockholders Equity 197,063
Total Stockholder Equity (as reported)15,470
Total Stockholder Equity (calculated)15,470
+/-0
Other
Cash and Short Term Investments 20,374
Common Stock Shares Outstanding 2,576
Current Deferred Revenue-2,619
Liabilities and Stockholders Equity 21,353
Net Debt -19,951
Net Invested Capital 15,470
Net Working Capital 15,050
Property Plant and Equipment Gross 1,805
Short Long Term Debt Total 423



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-06-302013-06-30
> Total Assets 
1,605
24,027
24,819
0
19,574
0
20,596
20,726
14,853
15,785
14,362
19,243
17,418
16,092
13,848
11,447
15,675
21,862
21,316
646
19,207
308
16,306
0
11,587
8,916
15,512
13,428
21,379
17,836
14,014
10,064
5,973
18,115
11,905
8,220
4,464
27,053
21,353
21,35327,0534,4648,22011,90518,1155,97310,06414,01417,83621,37913,42815,5128,91611,587016,30630819,20764621,31621,86215,67511,44713,84816,09217,41819,24314,36215,78514,85320,72620,596019,574024,81924,0271,605
   > Total Current Assets 
0
23,598
24,477
0
19,224
0
20,243
20,269
14,476
15,415
13,945
18,846
17,030
15,710
13,400
11,048
15,349
21,597
21,057
630
18,729
21,920
15,346
12,728
10,809
8,056
14,383
12,407
20,608
16,372
12,672
8,841
4,820
17,081
10,975
7,395
3,729
26,412
20,796
20,79626,4123,7297,39510,97517,0814,8208,84112,67216,37220,60812,40714,3838,05610,80912,72815,34621,92018,72963021,05721,59715,34911,04813,40015,71017,03018,84613,94515,41514,47620,26920,243019,224024,47723,5980
       Cash And Cash Equivalents 
1,455
20,512
21,948
0
16,711
0
16,574
15,223
13,614
10,216
8,840
15,007
13,352
11,532
8,011
8,085
11,816
16,750
16,332
528
15,695
260
13,762
0
9,801
7,450
14,010
11,988
19,769
15,727
12,329
8,630
4,062
16,534
10,537
6,551
2,477
25,864
20,374
20,37425,8642,4776,55110,53716,5344,0628,63012,32915,72719,76911,98814,0107,4509,801013,76226015,69552816,33216,75011,8168,0858,01111,53213,35215,0078,84010,21613,61415,22316,574016,711021,94820,5121,455
       Short-term Investments 
0
0
0
0
0
0
1,456
0
28
0
72
77
77
78
55
33
22
3
3
0
127
0
23
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000002301270332233557877777202801,456000000
       Net Receivables 
0
116
60
0
189
0
28
25
730
5,025
4,779
3,544
3,386
3,979
4,873
2,429
3,126
4,278
4,171
85
2,532
1,326
928
818
59
18
21
10
25
3
5
5
3
3
68
56
55
53
53
53535556683355325102118598189281,3262,532854,1714,2783,1262,4294,8733,9793,3863,5444,7795,025730252801890601160
       Inventory 
0
2,612
0
0
2,128
0
2,176
2,256
111
157
243
0
-65
0
0
0
0
0
0
0
0
0
0
0
948
587
0
0
0
0
0
0
0
0
0
14
13
13
14
1413131400000000058794800000000000-6502431571112,2562,17602,128002,6120
   > Long-term Assets 
0
429
342
0
350
0
354
457
378
370
417
397
387
382
449
398
326
0
259
0
478
0
960
0
778
860
1,129
1,021
771
1,464
1,342
1,223
1,153
1,034
930
825
735
641
527
5276417358259301,0341,1531,2231,3421,4647711,0211,1298607780960047802590326398449382387397417370378457354035003424290
       Property Plant Equipment 
26
429
342
0
350
0
354
457
378
325
374
352
342
336
321
273
234
198
193
670
469
1,358
951
843
769
851
910
815
577
1,270
1,156
1,042
993
890
789
695
613
531
451
4515316136957898909931,0421,1561,2705778159108517698439511,3584696701931982342733213363423523743253784573540350034242926
       Other Assets 
0
0
0
0
0
0
0
0
0
45
0
45
0
46
0
56
36
67
23
13
13
13
0
9
9
9
219
206
194
194
186
181
160
144
141
0
122
0
30
3001220141144160181186194194206219999013131323673656046045045000000000
> Total Liabilities 
1,018
1,546
588
0
1,259
0
730
1,706
786
732
1,005
897
891
1,361
1,420
1,316
1,906
1,553
1,514
89
2,637
20
1,083
0
1,349
1,180
887
2,498
1,369
2,361
3,178
2,544
3,091
3,502
2,911
3,507
4,262
4,745
5,883
5,8834,7454,2623,5072,9113,5023,0912,5443,1782,3611,3692,4988871,1801,34901,083202,637891,5141,5531,9061,3161,4201,3618918971,0057327861,70673001,25905881,5461,018
   > Total Current Liabilities 
1,018
1,546
588
0
1,259
0
730
1,693
773
710
985
871
865
1,333
1,390
1,281
1,871
1,547
1,508
89
2,637
1,080
756
981
1,136
1,019
779
2,444
1,369
1,601
2,480
1,909
2,532
3,011
2,489
3,153
3,978
4,534
5,746
5,7464,5343,9783,1532,4893,0112,5321,9092,4801,6011,3692,4447791,0191,1369817561,0802,637891,5081,5471,8711,2811,3901,3338658719857107731,69373001,25905881,5461,018
       Short-term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
181
0
192
198
203
208
213
194
213
232
252
258
263
269
275
280
286
28628027526926325825223221319421320820319819201810000000000000000000000
       Accounts payable 
256
716
197
0
583
0
384
1,391
402
212
467
227
134
541
641
158
426
251
244
49
2,490
142
99
288
282
299
87
1,640
274
323
1,946
100
422
608
531
635
1,140
1,528
2,619
2,6191,5281,1406355316084221001,9463232741,64087299282288991422,490492442514261586415411342274672124021,39138405830197716256
       Other Current Liabilities 
762
830
391
0
676
0
347
302
371
498
518
644
731
792
749
1,123
1,445
1,155
1,264
34
147
453
475
77
662
522
489
596
882
1,084
1,585
1,577
1,858
2,145
1,695
2,249
2,563
4,254
5,460
5,4604,2542,5632,2491,6952,1451,8581,5771,5851,08488259648952266277475453147341,2641,1551,4451,12374979273164451849837130234706760391830762
   > Long-term Liabilities 
0
0
0
0
0
0
0
13
13
22
19
25
27
28
30
35
35
0
6
0
0
0
327
0
213
161
108
54
0
760
698
635
559
491
422
354
284
211
137
137211284354422491559635698760054108161213032700060353530282725192213130000000
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
467
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000004670000000000000000000000
       Other Liabilities 
0
0
0
0
0
0
0
14
13
22
20
25
26
29
30
16
14
7
2
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000000027141630292625202213140000000
> Total Stockholder Equity
587
22,481
24,231
0
18,314
0
19,866
19,020
14,067
15,053
13,358
18,346
16,526
14,731
12,429
10,130
13,769
20,308
19,801
557
16,570
287
15,223
0
10,238
7,736
14,625
10,930
20,010
15,475
10,836
7,520
2,882
14,613
8,994
4,713
202
22,308
15,470
15,47022,3082024,7138,99414,6132,8827,52010,83615,47520,01010,93014,6257,73610,238015,22328716,57055719,80120,30813,76910,13012,42914,73116,52618,34613,35815,05314,06719,02019,866018,314024,23122,481587
   Retained Earnings -180,641-173,843-167,889-163,228-158,831-153,420-148,327-143,260-139,985-135,164-130,119-126,116-122,207-119,340-116,636-113,829-101,806-145,420-98,928-141,258-96,587-99,061-107,864-110,586-110,223-108,760-104,316-101,892-95,857-98,917-98,104-95,816-89,5290-82,6760-82,901-101,4850
   Accumulated Other Comprehensive Income 
0
1,919
1,141
0
1,563
0
1,898
1,772
1,915
1,364
1,079
1,204
1,286
1,429
1,299
1,325
1,096
0
806
0
582
0
319
0
-1,953
-1,775
-1,567
-1,591
-1,455
-1,216
-1,273
-1,506
-1,245
-738
-898
-853
-830
-780
-952
-952-780-830-853-898-738-1,245-1,506-1,273-1,216-1,455-1,591-1,567-1,775-1,95303190582080601,0961,3251,2991,4291,2861,2041,0791,3641,9151,7721,89801,56301,1411,9190
   Capital Surplus 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
128,826
0
138,395
138,632
0
0
0
0
0
0
0
0
0
0
0
00000000000138,632138,3950128,826000000000000000000000000
   Treasury Stock000000000000000000000000000000000000000



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2023-06-30)

Gross Profit (+$)
totalRevenue75
Cost of Revenue-381
Gross Profit-306-306
 
Operating Income (+$)
Gross Profit-306
Operating Expense-19,156
Operating Income-19,081-19,462
 
Operating Expense (+$)
Research Development12,774
Selling General Administrative6,382
Selling And Marketing Expenses-
Operating Expense19,15619,156
 
Net Interest Income (+$)
Interest Income-
Interest Expense-33
Other Finance Cost-0
Net Interest Income-33
 
Pretax Income (+$)
Operating Income-19,081
Net Interest Income-33
Other Non-Operating Income Expenses-
Income Before Tax (EBT)-19,562-18,633
EBIT - interestExpense = -19,144
-19,559
-19,529
Interest Expense33
Earnings Before Interest and Taxes (EBIT)-19,111-19,529
Earnings Before Interest and Taxes (EBITDA)-18,730
 
After tax Income (+$)
Income Before Tax-19,562
Tax Provision--
Net Income From Continuing Ops-19,562-19,562
Net Income-19,562
Net Income Applicable To Common Shares-19,562
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses19,156
Total Other Income/Expenses Net-44833
 

Technical Analysis of Benitec
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Benitec. The general trend of Benitec is BULLISH with 100.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Benitec's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (100.0%) Bearish trend (-100.0%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Benitec Biopharma Ltd ADR.

The long score for the Support & Resistance is 1/1.
The longshort score for the Support & Resistance is 1/(-1 +1).

  • Around support: The price is currently trading around a support level. This can be considered as a potential entry level. +1

The bullish price targets are: 9.01 < 16.15 < 18.02.

The bearish price targets are: 6.7235 > 6.29 > 4.75.

Tweet this
Benitec Biopharma Ltd ADR Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Benitec Biopharma Ltd ADR. The current mas is .

The long score for the Moving Averages is 14/14.
The longshort score for the Moving Averages is 14/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Benitec Biopharma Ltd ADR Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Benitec Biopharma Ltd ADR. The current macd is 0.44122477.

The long score for the Moving Average Convergence/Divergence (MACD) is 4/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 4/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Benitec price going up in the near term. +2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Benitec. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Benitec price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Benitec Biopharma Ltd ADR Daily Moving Average Convergence/Divergence (MACD) ChartBenitec Biopharma Ltd ADR Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Benitec Biopharma Ltd ADR. The current adx is 45.53.

The long score for the Directional Movement Index (DMI) is 4/7.
The longshort score for the Directional Movement Index (DMI) is 4/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Benitec shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX > 25 && ADX trending up: The ADX is above 25 and indicates a strong bullish trend. The ADX is trending up, so the bullish trend is strengthening.
Benitec Biopharma Ltd ADR Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Benitec Biopharma Ltd ADR. The current sar is 4.903752.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Benitec Biopharma Ltd ADR Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Benitec Biopharma Ltd ADR. The current rsi is 66.14. The current phase is Continuation in bull market.

The long score for the Relative Strength Index (RSI) is 4/13.
The longshort score for the Relative Strength Index (RSI) is 4/(-13 +13).

  • Continuation in bull market: Uptrend continues after a consolidation or pullback. Hold or add to existing positions.
  • Trending up: The RSI is trending up. +1
Benitec Biopharma Ltd ADR Daily Relative Strength Index (RSI) ChartBenitec Biopharma Ltd ADR Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Benitec Biopharma Ltd ADR. The current phase is Continuation in bull market.

The long score for the Stochastic Oscillator is 4/6.
The longshort score for the Stochastic Oscillator is 4/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Benitec price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Benitec Biopharma Ltd ADR Daily Stochastic Oscillator ChartBenitec Biopharma Ltd ADR Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Benitec Biopharma Ltd ADR. The current cci is 148.99.

The long score for the Commodity Channel Index (CCI) is 1/1.
The longshort score for the Commodity Channel Index (CCI) is 1/(-1 +1).

  • CCI > 100: The CCI is above 100, it indicates that the price is significantly above its average, suggesting a potential overbought condition. +1
Benitec Biopharma Ltd ADR Daily Commodity Channel Index (CCI) ChartBenitec Biopharma Ltd ADR Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Benitec Biopharma Ltd ADR. The current cmo is 35.33.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Benitec Biopharma Ltd ADR Daily Chande Momentum Oscillator (CMO) ChartBenitec Biopharma Ltd ADR Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Benitec Biopharma Ltd ADR. The current willr is -20.97378277.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Benitec is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Benitec Biopharma Ltd ADR Daily Williams %R ChartBenitec Biopharma Ltd ADR Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Benitec Biopharma Ltd ADR.

Benitec Biopharma Ltd ADR Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Benitec Biopharma Ltd ADR. The current atr is 0.57642345.

Benitec Biopharma Ltd ADR Daily Average True Range (ATR) ChartBenitec Biopharma Ltd ADR Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Benitec Biopharma Ltd ADR. The current obv is 48,439,720.

Benitec Biopharma Ltd ADR Daily On-Balance Volume (OBV) ChartBenitec Biopharma Ltd ADR Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Benitec Biopharma Ltd ADR. The current mfi is 97.45.

The long score for the Money Flow Index (MFI) is 2/2.
The longshort score for the Money Flow Index (MFI) is 2/(-2 +2).

  • MFI > 50: +1
  • MFI > 80: +1
Benitec Biopharma Ltd ADR Daily Money Flow Index (MFI) ChartBenitec Biopharma Ltd ADR Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Benitec Biopharma Ltd ADR.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-30DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-04SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-05DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-06STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-07DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-08CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-11DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-13MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-14WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-15DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-18CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-20MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-12-21STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-22MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-26WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-27STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-28CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-29CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-02STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-05STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-08STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-09STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-10MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-01-11STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-12STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-01-16MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-01-17STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-18STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-22MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-01-23STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-24STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-25STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-26CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-29MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-30STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-31MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-02-02STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-02-05MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-07SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-09STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-14STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-02-15DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-16CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-20DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-02-21DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-22WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-26SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-27MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-02-29STOCH LONG EXITThe %K line crosses below the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-01ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-04RSI SHORT ENTRY LONG CLOSE70 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-05STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-03-06RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2024-03-07STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-11STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-12STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-13STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-14STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-15MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-03-20STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-21STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-22SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-03-27STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-01STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-02STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-04-03SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-04-05STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-08WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-04-09MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-04-10MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-04-11MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-04-12RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-15MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-04-16CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-04-18SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-04-19MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-04-22STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-23STOCH SHORT EXITThe %K line crosses above the %D line.

6.3. Candlestick Patterns

Benitec Biopharma Ltd ADR Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Benitec Biopharma Ltd ADR based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5066.141
Ma 20Greater thanMa 505.681
Ma 50Greater thanMa 1004.933
Ma 100Greater thanMa 2004.017
OpenGreater thanClose6.570
Total4/5 (80.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Benitec with someone you think should read this too:
  • Are you bullish or bearish on Benitec? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Benitec? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Benitec Biopharma Ltd ADR

I send you an email if I find something interesting about Benitec Biopharma Ltd ADR.


Comments

How you think about this?

Leave a comment

Stay informed about Benitec Biopharma Ltd ADR.

Receive notifications about Benitec Biopharma Ltd ADR in your mailbox!